PATENT CLAIM ANALYSIS

Application Number: 16277689
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "045000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 26):
The method of  claim 24 , wherein each of the doses of the pharmaceutical composition comprises from about 10 mg to about 80 mg of cromolyn sodium, and administration of the pharmaceutical composition provides in the subject an AUC (0-\u221e)  of the cromolyn sodium of from 100 ng*hr/mL to 500 ng*hr/mL.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15887830', '15750811', '15750809', '14686535', '16273987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8030424513627358
- 35 USC 102 Novelty (BERT): 0.6343657717781824
- Combined Prediction Score: 0.7861747834042805
- Mean Citation Score: 431.317602
- Max Citation Score: 721.60675
- Similarity Product: 516.0062701734156

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test